HCPLive

Rheumatoid Arthritis
The MD Magazine Rheumatoid Arthritis condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

Latest Headlines

Gene Regulates Tissue Damage Severity in Rheumatoid Arthritis
Early diagnosis continues to be one of the biggest challenges associated with rheumatoid arthritis (RA); however, researchers have identified a genetic marker that can predict tissue damage severity that could lead to better treatments.
Study results suggest that longer exposure to methotrexate and other disease-modifying anti-rheumatic drugs within the first year of diagnosis is associated with a significantly longer time to joint replacement surgery.
Patients with rheumatoid arthritis may do better with subcutaneous methotrexate compared with oral dosing, according to findings published in the Annals of the Rheumatic Diseases.
Leflunomide, marketed under the brand name Arava, is a safe and effective treatment for early rheumatoid arthritis, according to a study in International Journal of Rheumatic Diseases.
A systematic review of alopecia areata (AA) in Clinical, Cosmetic & Investigational Dermatology highlighted the unpredictability and lack of treatment options for the condition. But it also pointed to a larger problem: more than half of patients with AA experience poor health-related quality of life (QOL). Patients with AA are at risk for depression and anxiety, atopy, vitiligo, thyroid disease, and other autoimmune conditions.
Treatment for rheumatoid arthritis may be delivered like a vaccine, according to findings from Science Translational Medicine.
Half of the patients with psoriatic arthritis enrolled in a trial of etanercept continued responding to the medication and complying with treatment guidelines for more than 5 years.

Most Popular

$vacMongoViewPlus$ $vAR$